Literature DB >> 30079865

Are the "Best Buys" for Alcohol Control Still Valid? An Update on the Comparative Cost-Effectiveness of Alcohol Control Strategies at the Global Level.

Dan Chisholm1,2,3, Daniela Moro4, Melanie Bertram5, Carel Pretorius6, Gerrit Gmel7, Kevin Shield7,8,9, Jürgen Rehm7,3.   

Abstract

OBJECTIVE: Evidence on the comparative cost-effectiveness of alcohol control strategies is a relevant input into public policy and resource allocation. At the global level, this evidence has been used to identify so-called best buys for noncommunicable disease prevention and control. This article uses global evidence on alcohol use exposures and risk relations, as well as on intervention costs and impacts, to re-examine the comparative cost-effectiveness of a range of alcohol control strategies.
METHOD: A "generalized" approach to cost-effectiveness analysis was adopted. A new modeling tool (OneHealth) was used to estimate the population-level effects of interventions. Interventions that reduce the harmful use of alcohol included brief psychosocial interventions, excise taxes, and the enactment as well as enforcement of restrictions on alcohol marketing, availability, and drink-driving laws. Costs were estimated in international dollars for the year 2010 and effects expressed in healthy life years gained. Analysis was carried out for 16 countries spanning low-, middle-, and high-income settings.
RESULTS: Increasing excise taxes has a low cost (<I$0.10 per capita) and a highly favorable ratio of costs to effects (<I$100 per healthy life year gained in both low- and high-income settings). Availability and marketing restrictions are also highly cost effective (<I$100 in low-income settings and <I$500 in high-income settings). Enforcement of drink-driving laws and blood alcohol concentration limits via sobriety checkpoints had cost-effectiveness ratios in the range of I$1,500-3,000. Brief psychosocial treatments were <I$150 and <I$1,500 in low- and high-income settings, respectively.
CONCLUSIONS: More than a decade after an initial global analysis, the findings of this study indicate pricing policies and restrictions to alcohol availability and marketing continue to represent a highly cost-effective use of resources.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30079865

Source DB:  PubMed          Journal:  J Stud Alcohol Drugs        ISSN: 1937-1888            Impact factor:   2.582


  55 in total

1.  A "buck a beer," but at what cost to public health?

Authors:  Kevin D Shield; Charlotte Probst; Jürgen Rehm
Journal:  Can J Public Health       Date:  2019-02-08

2.  Fewer Cancer Cases in 4 Countries of the WHO European Region in 2018 through Increased Alcohol Excise Taxation: A Modelling Study.

Authors:  Pol Rovira; Carolin Kilian; Maria Neufeld; Harriet Rumgay; Isabelle Soerjomataram; Carina Ferreira-Borges; Kevin D Shield; Bundit Sornpaisarn; Jürgen Rehm
Journal:  Eur Addict Res       Date:  2020-12-03       Impact factor: 3.015

3.  Alcohol and health in Central and Eastern European Union countries - status quo and alcohol policy options.

Authors:  Jürgen Rehm; Mindaugas Štelemėkas; Kawon Victoria Kim; Anush Zafar; Shannon Lange
Journal:  J Health Inequal       Date:  2021-12-31

4.  Prospective Analysis of Minimum Pricing Policies to Reduce Excessive Alcohol Use and Related Harms in U.S. States.

Authors:  Jennifer LeClercq; Stephanie Bernard; Francesca Mucciaccio; Marissa B Esser
Journal:  J Stud Alcohol Drugs       Date:  2021-11       Impact factor: 2.582

5.  Alcohol control policy measures and all-cause mortality in Lithuania: an interrupted time-series analysis.

Authors:  Mindaugas Štelemėkas; Jakob Manthey; Robertas Badaras; Sally Casswell; Carina Ferreira-Borges; Ramunė Kalėdienė; Shannon Lange; Maria Neufeld; Janina Petkevičienė; Ričardas Radišauskas; Robin Room; Tadas Telksnys; Ingrida Zurlytė; Jürgen Rehm
Journal:  Addiction       Date:  2021-04-06       Impact factor: 6.526

6.  What are the Economic Costs to Society Attributable to Alcohol Use? A Systematic Review and Modelling Study.

Authors:  Jakob Manthey; Syed Ahmed Hassan; Sinclair Carr; Carolin Kilian; Sören Kuitunen-Paul; Jürgen Rehm
Journal:  Pharmacoeconomics       Date:  2021-05-10       Impact factor: 4.981

7.  Commentary on Peña et al.: The broader public health relevance of understanding and addressing the alcohol harm paradox.

Authors:  Charlotte Probst; Carolin Kilian
Journal:  Addiction       Date:  2021-03-22       Impact factor: 6.526

8.  Alcohol and Tobacco Use in a Tuberculosis Treatment Cohort during South Africa's COVID-19 Sales Bans: A Case Series.

Authors:  Bronwyn Myers; Tara Carney; Jennifer Rooney; Samantha Malatesta; Laura F White; Charles D H Parry; Tara C Bouton; Elizabeth J Ragan; Charles Robert Horsburgh; Robin M Warren; Karen R Jacobson
Journal:  Int J Environ Res Public Health       Date:  2021-05-19       Impact factor: 3.390

9.  Validation of a screening test for alcohol use, the Russian Federation.

Authors:  Maria Neufeld; Jürgen Rehm; Anna Bunova; Artyom Gil; Boris Gornyi; Pol Rovira; Jakob Manthey; Elena Yurasova; Svetlana Dolgova; Bulat Idrisov; Marina Moskvicheva; Galina Nabiullina; Olga Shegaym; Irina Zhidkova; Zukhra Ziganshina; Carina Ferreira-Borges
Journal:  Bull World Health Organ       Date:  2021-03-19       Impact factor: 9.408

10.  Classifying Alcohol Control Policies with Respect to Expected Changes in Consumption and Alcohol-Attributable Harm: The Example of Lithuania, 2000-2019.

Authors:  Jürgen Rehm; Mindaugas Štelemėkas; Carina Ferreira-Borges; Huan Jiang; Shannon Lange; Maria Neufeld; Robin Room; Sally Casswell; Alexander Tran; Jakob Manthey
Journal:  Int J Environ Res Public Health       Date:  2021-03-02       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.